Sci-Tech News Network
Press release/News aggregator
The Global European is part of Affinity Group Publishing (AGP), a global network of more than 3,900 moderated digital publications from Newsmatics Inc. Our mission is to provide communities with timely, trustworthy news drawn from one of the largest collections of verified sources anywhere online. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | United States of America |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesDevart Celebrates 29 Years With 20% Off Database Management, Data Connectivity and Productivity Tools
Devart Celebrates 29 Years With 20% Off Devart marks 29 years of simplifying data work with continued innovation across database management, connectivity and AI-powered tools.
A' Virtual and Digital Art Installations Design Awards 2026 Call for Entries Announced
Virtual and Digital Art Installations Design Awards A' Virtual and Digital Art Installations Design Awards 2026 celebrates immersive, interactive and technology-driven artworks worldwide. COMO, CO, ITALY, August 18, 2026 / EINPresswire.com/ -- Today, A' Design Award & Competition has released its call for entries to A' International Virtual and Digital Art Installations Design Awards.
City Robotics: Why Autonomous Mobile Spaces Could Become the Next Layer of Urban Infrastructure
Moving Beyond Conventional Autonomous Vehicles to Build Dynamic, Deployable Urban Service Platforms CALIFORNIA, CA, UNITED STATES, August 18, 2026 / EINPresswire.com/ -- Every city that wants to stay livable faces the same difficult question: how do you keep people, goods, and services moving when transport systems are stretched, drivers are scarce, and infrastructure budgets are under pressure?
Synthesized Introduces Test Data Agent, Bringing Production-Faithful Validation to Enterprise AI Agents
Framework-agnostic and PII-free, Test Data Agent provisions realistic data and environments so enterprise teams can validate, and continuously improve, AI agents before production, including on SAP. London, GREATER LONDON, Aug.
Basilea erzielt starkes Halbjahresergebnis 2026 und erhöht die Finanzprognose für das Gesamtjahr; Phase-3-Programm mit Fosmanogepix auf Kurs
14 % Wachstum des Gesamtumsatzes auf CHF 119 Mio. 32 % Steigerung des Betriebsgewinns auf CHF 32 Mio. und 77 % Steigerung des Gewinns auf CHF 28 Mio. Phase-3-Programm mit Fosmanogepix auf Kurs für die Auswertung der Studiendaten und Einreichung des Zulassungsantrags im Jahr 2028 Anhebung der Finanzprognose (Guidance) für das Gesamtjahr 2026: Steigerung des Betriebsgewinns um 40 % aufgrund höherer Umsätze Telefonkonferenz und Webcast heute um 16 Uhr (MESZ) Ad hoc-Mitteilung gemäss Art.
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ARS Pharmaceuticals, Inc. (SPRY), Alarum Technologies Ltd. (ALAR), and HDFC Bank Limited (HDB) Announced by Holzer & Holzer, LLC
ATLANTA, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: ARS Pharmaceuticals, Inc. (SPRY) The shareholder class action lawsuit filed against ARS Pharmaceuticals, Inc.
Intuitive Machines Selected to Provide Spacecraft Platform and Mission Solutions for NASA's EAGLE-VSWIR Earth Science Mission
HOUSTON, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR) ("Intuitive Machines," and together with its subsidiaries, the "Company"), a leading space technology, infrastructure, and services company, today announced that it has been selected by NASA's Jet Propulsion Laboratory in Southern California to provide the spacecraft platform, system-level integration, and mission solutions for EAGLE-VSWIR, an Earth observation mission under NASA's Earth Science Division.
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
Dr. Charuworn’s extensive immunology drug development experience will help accelerate the clinical development of Coultreon’s first-in-class SIK3 inhibitor COL-5671 Leuven, Belgium. August 18, 2026. Coultreon Biopharma, a clinical-stage biotechnology company developing best-in-class immunology therapies, today announced the appointment of Prista Charuworn, MD, as Chief Medical Officer.
NANO Nuclear and Quadrant Nuclear Industries Sign Memorandum of Understanding to Advance Domestic HALEU Fuel Supply
Companies to explore long-term HALEU supply arrangement supporting advanced reactor deployments and strengthening the U.S. nuclear fuel supply chain New York, N.Y., and Boston, Massachusetts., Aug. 18, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, and Quadrant Nuclear Industries, Inc.
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
Dr. Camisasca joins Entera with 30 years of global pharmaceutical research and clinical development experience including roles at Sumitomo Pharma, Takeda, and Novartis Appointment further strengthens Entera’s clinical execution team and late-stage development capabilities ahead of planned EB613 Phase 3 initiation TEL AVIV, Israel, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd.